Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 4 of 4 entries
View as:
Phase: N/A
Priority: Normal
Start: 03/15/25
End: 12/31/26
Due: 12/31/27
Phase: N/A
Priority: Normal
Start: 02/28/19
End: 03/26/20
Due: 03/26/21
Phase: N/A
Priority: Normal
Start: 01/31/21
End: 01/31/21
Due: 01/31/22
Phase: N/A
Priority: Normal
Start: 07/09/17
End: 01/15/20
Due: 01/15/21
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| A-TANGO Phase 2 Study | NCT06890039 | Yaqrit Ltd | user2@example.com | None | 2025-03-15 | 2026-12-31 | 2027-12-31 | - | - | 2025-07-14 |
| Safety and Tolerability of Yaq-001 in Patients With Cirrhosis | NCT03202498 | Yaqrit Ltd | user2@example.com | None | 2019-02-28 | 2020-03-26 | 2021-03-26 | - | - | 2025-07-14 |
| Safety and Tolerability of Yaq-001 in Patients With Non-Alcoholic Steatohepatitis | NCT03962608 | Yaqrit Ltd | user2@example.com | None | 2021-01-31 | 2021-01-31 | 2022-01-31 | - | - | 2025-07-14 |
| Safety and Performance Trial of DIALIVE Liver Dialysis Device in Acute On Chronic Liver Failure Patients | NCT03065699 | Yaqrit Ltd | user2@example.com | None | 2017-07-09 | 2020-01-15 | 2021-01-15 | - | - | 2025-07-14 |